Adjuvant trastuzumab in HER2-positive breast cancer
D Slamon, W Eiermann, N Robert… - New England journal …, 2011 - Mass Medical Soc
Background Trastuzumab improves survival in the adjuvant treatment of HER-positive breast
cancer, although combined therapy with anthracycline-based regimens has been …
cancer, although combined therapy with anthracycline-based regimens has been …
[引用][C] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
D Slamon, W Eiermann, N Robert… - New England Journal …, 2011 - cir.nii.ac.jp
Adjuvant trastuzumab in HER2-positive breast cancer.
D Slamon, W Eiermann, N Robert… - The New England …, 2011 - espace.curtin.edu.au
Trastuzumab improves survival in the adjuvant treatment of HER-positive breast cancer,
although combined therapy with anthracycline-based regimens has been associated with …
although combined therapy with anthracycline-based regimens has been associated with …
[引用][C] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
D SLAMON, W EIERMANN, T PINTER… - The New England …, 2011 - pascal-francis.inist.fr
Adjuvant Trastuzumab in HER2-Positive Breast Cancer CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Adjuvant trastuzumab in HER2-positive breast cancer
D Slamon, W Eiermann, N Robert, T Pienkowski… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Trastuzumab improves survival in the adjuvant treatment of HER-positive breast
cancer, although combined therapy with anthracycline-based regimens has been …
cancer, although combined therapy with anthracycline-based regimens has been …
[HTML][HTML] Adjuvant Trastuzumab in HER2-Positive Breast Cancer
D Slamon, W Eiermann, N Robert… - The New England …, 2011 - ncbi.nlm.nih.gov
BACKGROUND Trastuzumab improves survival in the adjuvant treatment of HER-positive
breast cancer, although combined therapy with anthracycline-based regimens has been …
breast cancer, although combined therapy with anthracycline-based regimens has been …
Adjuvant trastuzumab in HER2-positive breast cancer.
MC Liu, G Sauter, G von Minckwitz, F Visco, V Bee… - N Engl J Med, 2011 - aris-rs.si
Slika ali diapozitiv (velikost pisave ARIAL 18) v zvezi z opisom področja (npr. graf na
podlagi analize v zvezi s področjem ip Page 1 Eden od 400 sodelavcev Breast Cancer …
podlagi analize v zvezi s področjem ip Page 1 Eden od 400 sodelavcev Breast Cancer …
Adjuvant trastuzumab in HER2-positive breast cancer.
D Slamon, W Eiermann, N Robert… - The New England …, 2011 - europepmc.org
Background Trastuzumab improves survival in the adjuvant treatment of HER-positive breast
cancer, although combined therapy with anthracycline-based regimens has been …
cancer, although combined therapy with anthracycline-based regimens has been …
Adjuvant trastuzumab in HER2-positive breast cancer.
MC Liu, G Sauter, G von Minckwitz, F Visco, V Bee… - N Engl J Med, 2011 - arrs.si
Slika ali diapozitiv (velikost pisave ARIAL 18) v zvezi z opisom področja (npr. graf na
podlagi analize v zvezi s področjem ip Page 1 Eden od 400 sodelavcev Breast Cancer …
podlagi analize v zvezi s področjem ip Page 1 Eden od 400 sodelavcev Breast Cancer …
Adjuvant trastuzumab in HER2-positive breast cancer.
D Slamon, W Eiermann… - The New …, 2011 - mdanderson.elsevierpure.com
Trastuzumab improves survival in the adjuvant treatment of HER-positive breast cancer,
although combined therapy with anthracycline-based regimens has been associated with …
although combined therapy with anthracycline-based regimens has been associated with …